Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies.

doi:10.7314/apjcp.2014.15.22.9643

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2014

Chen Wei, Yang Heng, Tang Wen-Ru, Feng Shi-Jun, Wei Yun-Lin

Abstract excerpt

BACKGROUND: Several studies have been performed to investigate the association of the HER2 Ile655Val polymorphism and breast cancer risk. However, the results were inconsistent. To understand the precise relationship, a meta-analysis was here conducted. MATERIALS AND METHODS: A search of PubMed conducted to investigate links between the HER2 Ile655Val polymorphism and breast cancer, identified a total of 32...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genetic Predisposition to Disease
Share to Polymorphism, Single Nucleotide
Share to Receptor, ErbB-2

Source

Open in PubMed

Identifiers

PMID: 25520082
DOI: 10.7314/apjcp.2014.15.22.9643

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Risk